Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
Globe Newswire12-06-2023, 13:00
The McWhorter Foundation To Call On Sequoia Capital and Industry Leaders Alongside C.K. McWhorter For Support In Further Diversifying Tech Entrepreneurship 2-04-2024, 13:22